Naomi Birbach is an associate in Goodwin’s IP Litigation group. She joined the firm in 2013.
Ms. Birbach focuses her practice on intellectual property litigation in U.S. district courts and before the U.S. Patent and Trademark Office Patent Trial and Appeal Board (PTAB) in post-grant proceedings such as inter partes reviews (IPRs). She has worked on cases involving pharmaceuticals, electronic devices, and display systems. Ms. Birbach has particular expertise in generic drug litigation under the Hatch-Waxman Act.
Ms. Birbach is also an editor of the firm’s biosimilars blog, Big Molecule Watch, which provides resources and observations through Goodwin’s active watch of legal, business and regulatory developments related to biologics, biosimilars and the Biologics Price Competition and Innovation Act (BPCIA).
Ms. Birbach has experience representing companies in all stages of patent litigation, from pre-suit investigation through trial and appeal. Some of her representative matters include:
Ms. Birbach is member of the New York Intellectual Property Law Association (NYIPLA).
Prior to entering law school, Ms. Birbach was a patent examiner at the U.S. Patent and Trademark Office.
While attending law school, Ms. Birbach was an articles and notes editor of the American Criminal Law Review.
(cum laude)
Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.
Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.
客户信赖我们世界一流的咨询服务，希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题，涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息，请与我们联系。